Upload
others
View
9
Download
0
Embed Size (px)
Citation preview
REFERENCES
1. C.K. Kokate, A. P. Purohit, S.B. Gokhale., (2002) Pharmacognosy 13th
edition, Nirali Prakashan, Page. 1-14.
2. C.S. Shah, J.S. Quadry., (1995) Text Book of Pharmacognosy 11th
edition Page. 3.
3. Anonymous (1998) NBRI News Letter.
4. B. Dhar, K.V. Billore, O.P. Gupta., (2003) An evaluation of some
controversial Ayurvedic Drugs of Indian Pharmaceutical industry. Recent
Progress of Indian Medicinal plants 1st edition Vol. 1. Page. 307-309.
5. B.N. Dhavan., (2002) Prioritising Indian Flora for drug development, IDMA
Bulletin Vol. 33(6) Page. 140.
6. Pulok. K. Mukherjee., (2001) Quality control of Herbal Medicines, 1st
edition, Page.492-505.
7. Girish Dwivedi, Shridhar Dwivedi., (2007) History of Medicine: Sushruta –
the Clinician –Teacher par Excellence, National Informatics Centre, Page.
224-225.
8. Ernst E (2007). Herbal medicines: balancing benefits and risks. Novartis
Foundation Symposium, 282 Page. 154–67.
9. Huffman MA., (2003). Animal self-medication and ethno-medicine:
exploration and exploitation of the medicinal properties of plants.
Proceedings of Nutrition Society, 62 (2): 371–81.
10. Bruneton.J.,(1999). Pharmacognosy,Phytochemistry,Medicinal plants”
2nd Edition ; Lavoisier Publication France, Page. 12-30
11. Subramanian S., Sekhar.D.S. (2006) Hypolipidemic Effect Of Momordica
charantia seed extract on streptozotocin induced diabetic rats; J.Natural
remedies, 6(2) 41-52
12. Dandagi.P.M, Patil.M.B, Masthiholimath V.S, Gadg.A.P,
Dhumansure.R.H. (2008) Development and evaluation of
hepatoprotective polyherbal formulation containing some indigenous
medicinal plants , Indian Journal of pharmaceutical sciences. 26-268
13. Sikarwar, Mukesh Singh. (2011) Formulation and evaluation of some Indian
Medicinal plants for antidiabetic and Antihyperlipidemic activity. Diss. KLE
University, Belgaum, Karnatka, 2011. Page. 22-24
14. V.V. Sivarajan., Indira Balachandran., (1994) Ayurvedic Drugs and their
Plant Sources. Oxford and IBH Publishing Company. Page. 3-14.
15. F.Leena Tripathi and Jaindra Nath Tripathi., (2003) Role of biotechnology
in medicinal plants. Tropical Journal of Pharmaceutical Research, 2
(2):243-253.
16. S.J. Murch, S.Krishna Raj , P.K. Saxena.(2000) Tryptophan is a
precursor for melatonin and serotonin biosynthesis in in-vitro
regenerated St. John's wort (Hypericum perforatum L. CV. Anthos)
plants. Plant Cell Report. Vol. 19 Page. 698-704.
17. R.K. Issar.,S.S.Pant.,(1996) Bullettin of Medico-Ethnobotanical Research
Vol.17(1) Page. 1.
18. History as a tool in identifying new old drugs. (2002) Adv Exp Med Biol.
(505): 89– 94.
19. S. Chidambarathanu Pillai., (1992) Siddha System of Pharmacopoeia.
Siddha Medical Literature research Centre. Page 2-3.
20. Greenlee H (2012) Natural Products for Cancer Prevention. Semin Oncol
Nurs 28: 29-44.
21. Heinrich M (2010) Ethnopharmacology and Drug Discovery.
Comprehensive Natural Products II 3: 351-381.
22. Varro. E. Tyler, Lynn. E. Braddy, James. E. Robbere., (1991)
Pharmacognosy. Page. 17-23.
23. F.Leena Tripathi and Jaindra Nath Tripathi., (2003) Role of
biotechnology in medicinal plants Tropical Journal of Pharmaceutical
Research, Vol. 2 (2):243-253.
24. S.J. Murch, S.Krishna Raj , P.K. Saxena.(2000) Tryptophan is a
precursor for melatonin and serotonin biosynthesis in in-vitro
regenerated St. John's wort (Hypericum perforatum L. cv. Anthos) plants.
Plant Cell Report. Vol.19:698-704.
25. S.J. Murch, S.Krishna Raj , P.K. Saxena.(2000) Tryptophan is a
precursor for melatonin and serotonin biosynthesis in in-vitro
regenerated St. John's wort (Hypericum perforatum L. cv. Anthos) plants.
Plant Cell Rep. Vol. 19:698-704.
26. K.Y. Park K.J. Yu, S.I. Park, N.S. Sung, C.H. Park., (1995)
Micropropagation of Rehmannia glutinosa as medicinal plant by shoot tip
and root segment culture. Acta Horticult. Vol.39(1):113-120.
27. Blondeau S, Do QT, Scior T, Bernard P, Morin-Allory L. (2010) Reverse
pharmacognosy: another way to harness the generosity of nature.
Current Pharma Desertation 2010, 16(15):1682–1696.
28. Inic S, Kujundzic N(2011) The first independent pharmacognosy institute
in the world and its founder Julije Domac (1853–1928). Pharmazie 2011,
66(9):720–726.
226
226
29. Moattar F, Ghannadi A. (2011) Jorjani. General introduction. Journal of
Islamic Iranian Traditional Medicine, 1(4):397–402.
30. Shinde V, Dhalwal K, Mahadik KR. (2008) Some issue related to
pharmacognosy. Pharmacognosy Review, 2(3):1–5
31. Mahnaz Kazemi1 , Azadeh Eshraghi , Afsaneh Yegdaneh and Alireza
Ghannad. (2012) DARU Journal of Pharmaceutical Sciences,20:18
32. Jenkins N. (2010) Clinical pharmacy: evidence, ethics and medication
management in older people. Australian Jouranal of Pharmacy91(10):92–
95.
33. National cholesterol education program. (1994) Second report of the
expert panel on detection, evaluation and treatment of high blood
cholesterol in adults. Page.1333-1445.
34. Richard J P Cannel. (1998) Natural Product isolation. Human Press
Totowa, New Jersy. Page1-14.
35. Kishor Jain S, Kathivarin MK, Rahul S, Chamanal J. (2007)The biology
and chemistry of hyperlipidemia.Bioorganic And Medicinal Chemistry,15:4
674-4699.
36. Zalba G, San JG, Moreno MU, Fortuno A, Beaumont FJ, Diez J. (2001),
Role of NADPH oxidase. Hypertension, 38: 1395–1399.
37. Huynh Ngoc T, Nguyen Ngoc Q, Tran T Van A,Vo Phung N. (2008)
Hypolipidemic Effect of Extracts from Abelmoschus esculentus L.
(Malvaceae) on Tyloxapol-Induced Hyperlipidemia in Mice: Mahidol
University. Journal of Pharmaceutical Sciences, 35(1-4):42-46.
38. Bhatnagar D, Soran H, Durrington PN. (2008) Hypercholesterolaemia
and its management. British Medical Journal, 33(7):993.
227
227
39. Grundy SM, Balady GJ, Criqui MH. (1998) Primary prevention of coronary
heart disease: guidance from Framingham: a statement for healthcare
professionals from the AHA Task Force on Risk Reduction. American
Heart Association. Circulation, 97(18):1876–87.
40. Keane WF, Peter J, Kasiske BL. (1992) Is the aggressive management of
hyperlipidemia in nephrotic syndrome mandatory. Kidney International,
(suppl 38), S134-41.
41. Hopkins PN. (2003) Coronary artery disease risk in familial combined
hyperlipidemia and familial hypertriglyceridemia: a case-control
comparison from the National Heart, Lung, and Blood Institute Family
Heart Study. Circulation, 108:519-523.
42. K.Harikumar, S. Abdul Althaf, B. Kishore kumar, M. Ramunaik, CH.
Suvarna.(2013) A Review on Hyperlipidemic . International journal of
novel trends in Pharmaceutical Sciences,3(4):59-71.
43. Ford ES, Giles WH, Dietz WH. (2002) Prevalence of the metabolic
syndrome among US adults: findings from the third national health and
nutrition examination survey. JAMA, 287:356-359.
44. Jap TS, Jenq SF, Wu YC, Chiu CY, Cheng HM. (2003) Mutations in the
lipoprotein lipase gene as a cause of hypertriglyceridemia and
pancreatitis in Taiwan. Pancreas, 27:122-126.
45. Ylitalo K. (2002) LDL particle size in familial combined hyperlipidemia:
effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer
proteins. Journal of. Lipid Research 43:598-603.
46. Chiba H. (2003) Two cases with transient lipoprotein lipase (LPL) activity
impairment: evidence for the possible involvement of an LPL inhibitor.
European Journal of. Pediatrics,162:132-138.
228
228
47. Lipman TH, Hayman LL, Fabian CV, DiFazio DA, Hale PM, Goldsmith
BM. (2000) Risk factors for cardiovascular disease in children with type I
diabetes. Nursing Research,49(3):160-166.
48. Genest J, Libby P. (2011) Lipoprotein disorders and cardiovascular
disease. Braunwald's Heart Disease: A Textbook of Cardiovascular
Medicine; 9th ed. Philadelphia, PA Saunders, Elsevier,Page. 47.
49. Ray KK, Seshasai SR, Erqou S. (2010) Statins and all-cause mortality in
high-risk primary prevention: a meta analysis of 11 randomized
controlled trials involving 65,229 participants. Achieves of Internal
Medicine, 170(12): 1024–31.
50. Abourbih S, Filion KB, Joseph L, Schiffrin EL, Rinfret S, Poirier P, Pilote
L, Genest J, Eisenberg MJ. Effect of fibrates on lipid profiles and
cardiovascular outcomes: a systematic review. Am J Med, 2009,
122(10), 962.e1–962.
51. Wong NN. Colesevelam (2001) A new bile acid sequestrant. Heart
disease, 3(1): 63–70.
52. Bhatt. (2010) Effects of antioxidant vitamins along with atorvastatin and
atorvastatin–niacin combination on diet-induced hypercholesterolemia in
rats. International Journal of Physiology Pathophysiology and
Pharmacology, 2(1):57-63.
53. Ghani A. (2003) Medicinal Plants of Bangladesh with Chemical
Constituents and Uses. 2nd ed. Dhaka, Asiatic Society of
Bangladesh.Page. 10.
229
229
54. Dr. Nandkarni KM. (1976) Indian Materia Medica. Mumbai: Bombay
Popular Prakashan. 1: 165-6.
55. Warrier PK, Nair RV. (2002) Indian Medicinal plants: A compendium of
500 species, Madras: Orient Longman. Page. 224
56. Thomas S, Patil DA, Patil A .Gand Narseh Chandra. (2008)
Pharmacognostic evalution & physiochemical analysis of A.C L. fruit.
Journal of Herbal medicine & Toxicology, 2(2): 51-54
57. Sheth A, K Ashok. (2005) The Herbs of Ayurveda. Sheth publisher,
Herbal Medicine Research Centre, Institute for Medical Research,
Kualalampur. Compendium of Medicinal Plants used in Malaysia,1:92.
58. Anitha Roy, Geetha RV, Lakshmi T. (2011) Averrhoa bilimbi Linn– Nature’s Drug Store- A Pharmacological Review, International Journal of
Drug Development & Research, 3(3)75-79
59. Kamrul Islam Siddique. (2013) Phytochemical screenings, thrombolytic
activity and antimicrobial properties of the bark extracts of Averrhoa
bilimbi, Journal of Applied Pharmaceutical Science,3(03):094-096.
60. K. Ashok Kumar, SK. Gousia, Anupama, M. And J. Naveena Lavanya
Latha. (2013) A Review On Phytochemical Constituents And Biological
Assays Of Averrhoa Bilimbi. International Journal of Pharmacy and
Pharmaceutical Science Research 2013; 3(4): 136-139
61. Qingwei Wen, Xing Lin, Yeqi Liu, XiaohuiXu, Tao Liang, Ni Zheng,
KintokoKintoko and Renbin Huang. (2012), Phenolic and Lignan
Glycosides from the Butanol Extract of Averrhoacarambola L. Root.
Molecules, 17: 12330-12340.
62. A K. Azeem, Molly Mathew, Chandramohan Nair, Dilip C. (2010),
Hepatoprotective effect of Averrhoacarambola fruit extract on carbon
230
230
tetrachloride induced hepatotoxicity in mice. Asia pacific journal of
Tropical medicine, 3(8): 412-420.
63. Pal R. and Sarkar T. (2014), Visible Light Induced Knoevenagel
Condensation Catalyzed by Starfruit Juice of Averrhoacarambola.
International Journal of Organic Chemistry,4:106-115.
64. L.C.A. Gunasekara, P.H.P. Fernando and R. Sivakanesan. (2011), A
Preliminary Study on the Hypoglycaemic Effect of Averrhoacarambola
(Star Fruit) in Rats. Proceedings of the Peradeniya University Research
Sessions, Sri Lanka,16: 24.
65. BiswaNath Das and Muniruddin Ahmed. (2012), Analgesic activity of the
fruit extract of Averrhoacarambola. International journal of Life Sciences
Biotechnology and Pharma Research, 1(3): 1-4.
66. SayaliNapahde, Annika Durve, D.Bharati and Naresh Chandra.
(2010),Wine Production from Carambola Juice Using Averrhoacarambola
Saccharomyces cerevisiae. Asian Journal of.Experimental Biological
Sciences.Spl.10: 20-23
67. Chin-Tung Chang, M.D., Yung-Chang Chen, M.D., Ji-Tseng Fang, M.D.
and Chiu-Ching Huang., M.D. (2002), Star Fruit ( Averrhoacarambola)
intoxication: An important cause of consciousness disturbance in patients
with renal failure. Renal failure, 24(3): 379–382.
68. Yin Sze Lim and Shi Ting Lee. (2013), In vitro Antioxidant Capacities of
Star Fruit (Averrhoacarambola ), an Underutilised Tropical Fruit. Journal
of Biology,1(1): 21- 24.
69. Narain N., Bora, P S., Holschuh H J. Vasconcelos M. A. Da S. (2013),
Physical and chemical composition of CarambolaFruit
231
231
(Averrhoacarambola L.) at three stages of maturity.Cienc. Tecnol.
Aliment,3(3): 144-148.
70. Daniela Almeida Cabrini, Henrique Hunger Moresco, PriscilaImazu,
CıntiaDelai da Silva, EveliseFernandesPietrovski, Daniel Augusto
GasparinBueno Mendes,
Arthur da SilveiraPrudente, Moacir Geraldo Pizzolatti, Ines Maria Costa Bri
ghentand Michel FleithOtuki. (2011), Analysis of the Potential Topical Anti-
Inflammatory Activity of Averrhoacarambola L. in Mice. Evidence-Based
Complementary and Alternative Medicine, 2011:1-7.
71. Avinash G. Patil, Darshana A. Patil, Anita V. Phatak and Naresh Chandra.
(2010), Physical and chemical characteristics of Carambola
(Averrhoacarambola L) fruit at three stages of maturity. International
Journal of Applied Biology and Pharmaceutical Technology, 2(1): 624-629.
72. Suman das. (2012), Antimicrobial and Antioxidant activities of green and
ripe fruits of Averrhoacarambola Linn. And Zizyphusmauritiana Lam.
Asian Journal of Pharmaceutical and Clinical Research, 5(3): 102-105.
73. GheewalaPayal, KalariaPankti, ChakrabortyManodeep, KamathJagadish
V. (2012), Phytochemical and pharmacological profile of
Averrhoacarambola Linn: An overview. International Research Journal Of
Pharmacy, 3 (1): 88- 92.
74. Luisa Helena Cazarolli, VirgíniaDemarchiKappel, Danielle Fontana
Pereira, Henrique Hunger Moresco, Ines Maria Costa Brighente, Moacir
Geraldo Pizzolatti, Fatima Regina Mena Barreto Silva (2012). Anti-
hyperglycemic action of apigenin-6-C-β-fucopyranoside from
Averrhoacarambola. Fitoterapia, 8( October 2012): 1176–1183.
75. Shih-Wen Hung, MD; AmingChor-Ming Lin, MD; Chee-Fah Chong, MD;
Tzong-Luen Wang, MD, PhD; Hon-Ping Ma, MD Fatal Outcome after Star
232
232
Fruit (AverrhoaCarambola) Ingestion in Patient with Chronic Renal
Insufficiency. (2004), Ann Disaster Med,3(1): 56- 59.
76. Simone T. Goncalves, SilmaraBaroni, Fernando A. Bersani-Amado,
GessildaA.N. Melo, Diogenes A.G. Cortez, Ciomar A. Bersani-Amado and
Roberto K.N. Cuman. (2006), Preliminary Studies on Gastric Anti-
ulcerogenic Effects of Averrhoacarambola in Rats. Acta Farm.
Bonaerense, 25(2): 245-7
77. Md. Masum Mia, Mohammad S. Rahman, Kohinur Begum, Bilkis Begum
and Mohammad A. Rashid. (2007), Phytochemical and Biological Studies
of Averrhoacarambola. Dhaka University Journal of Pharmaceutical.
Science,6(2): 125-128.
78. Vera Lucia arroxelasgalvao de lima, Enayde de almeidamelo, Lueci dos
santos lima. (2011), Physicochemical characteristics of Bilimbi
(averrhoabilimbi l.). Rev. Bras. Frutic.,Jaboticabal, 23(2): 421-423.
79. Gloria D. Masilungan and Wella L. Absulio. (2012), Fruits of Bilimbi
(Averrhoabilimbi L.) as a New Natural Source of Ethylene for
Ripening of ‘Saba’ Banana (Musa balbisiana BBB). Philipp Agric Scientist,
95(4): 406–410.
80. P Dasgupta, P Chakraborty, N N. Bala. (2013), AverrhoaCarambola: An
Updated Review International Journal of Pharma Research & Review,2(7):
54-63.
81. PatilAvinash, KoliSwapneel, PatilDarshana and Phatak Anita. (2012), A
Comprehensive Review of An Important Medicinal Plant –
Averrhoacarambola L. Pharmacognosy Communications, 2(2): 13-17.
82. A K. Azeem, ArunRasheed, C. Dilip, Prasanth S S, Shebina P Rasheed
and Tina Thomas. (2013), Invitro anthelminthic activity of
233
233
Averrhoacarambolaleaf extracts. Journal of chemical and Pharmaceutical
Research,5(1): 296-298.
83. Anitha Roy , Geetha R V, Lakshmi T. (2011), Averrhoabilimbi Linn– Nature’s Drug Store- A Pharmacological Review. International Journal of
Drug Development & Research, 3(3):101-106.
84. K. Ashok Kumar, S K .Gousia, Anupama M. And J.
NaveenaLavanyaLatha. (2013), A review on phytochemical constituents
and biological assays of Averrhoabilimbi. International Journal of
Pharmacy and Pharmaceutical Science Research,3(4): 136-139.
85. Md. Ramjan Ali, MarjanHossain, JannatulFerdousRuna, Md.
Hasanuzzaman. (2013), Preliminary cytotoxic activity of different extracts
of Averrhoabilimbi (fruits). International Current Pharmaceutical Journal,
2(3): 83-84.
86. Sabiha Sultana Chowdhury, GolamMezbahUddin, NaziaMumtahana,
MokarramHossain and S.M. RaquibulHasan. (2012), In vitro antioxidant
and cytotoxic potential of hydromethanolic extract of Averrhoabilimbi L.
fruits. International Journal of Pharmaceutical Science and Research,3(7):
2263-2268.
87. Md. Hasanuzzaman, Md. Ramjan Ali, MarjanHossain, SourovKuri,
Mohammad Safiqul Islam. (2013), Evaluation of total phenolic content,
free radical scavenging activity and phytochemical screening of different
extracts of Averrhoabilimbi fruits. International Current Pharmaceutical
Journal, 2(4):92-961.
88. P. Pushparaj, C H. Tan, B K H. Tan. (2000), Effects of Averrhoabilimbi leaf
extract on blood glucose and lipids in streptozotocin-diabetic rats. Journal
of Ethnopharmacology, 72 (2000): 69 – 76.
234
234
89. V. N. Ariharan, K. Kalirajan, V. N. Meena Devi and P. Nagendra Prasad.
(2012) An Exotic Fruit Which Forms The New Natural Source For
Vitamin-C. Rasayan Journal of Chemistry, 5(3): 356-359.
90. Farah Amna Othman, NooraainHashim, Noriham Abdullah, Azizah Abdul
Hamid, MohamadFaiz Fong Abdullah , ZainonMohd Noor, Normah Ismail,
Wan RozianoorMohd Hassan, NurulHusnaRosli. (2014), Toxicity
evaluation of A. bilimbiLinn fruit extract on Haematological and
Histopathological evaluation in animal model. International journal of
Pharmaceutical science Review and Research,26(2): 39-43.
91. Nurul Hanani Mohamad Zaki, Halimahton Zahrah Mohamed Som ,
Zaibunnisa Abdul Haiyee. (2012) Application Of Palm Stearin
Chitosan Edible Coating On Star Fruits (Averrhoa carambola L.) The
Malaysian Journal of Analytical Sciences,16(3): 325 – 334
92. Soumya S L. and Bindu R Nair. (2014), Changes in the biochemical profile
of fruits of two species of Averrhoaduring development. International
journal of Pharmavy and Pharmaceutical Sciences,6(4): 572-577.
93. Mahanom H. ,Azizah A H and Dzulkifly MH. (1999), Effect of different
drying methods on concentrations of several phytochemicals in herbal
preparation of 8 medicinal plants leaves. Malasyian Journal of Nutrition, 5:
47-54.
94. K. Monalisa, M. Z. Islam, S. M. Asif-Ul-Alam, M. M. Hoque (2014)
Valorization and Storage Stability Assessment of Underutilized Fruit
Carambola (Averrhoa carambola) in Bangladesh. American Journal of
Food Science and Technology, 2(4): 134-138
95. Erasmo Herman Lara, Jesus Rodriguez Miranda, Juan G.Torruco
Uco, Roselis CarmonaGarcia, Patricia G. Mendoza Garcia, Hugo S.
Garcia, Ida Soto- Rodriguez, Enrique Sanchez Valdivieso, and Cecilia E.
235
235
Martinez-Sánchez. (2014) Impact of micronized star fruit (Averrhoa
carambola L.) fiber concentrate on lipid metabolism in mice. International
journal of food science and nutrition, 65(7): 862-867.
96. MohdRazi Ismail, KhuzaimahMohd Noor. (1996), Growth, water relations
and physiological processes of starfruit (Averrhoacarambola L) plants
under root growth restriction.Scientia horticulturae,66(12): 51-58.
97. M. Khalekuzzaman, M.F Alam, M Nuruzzaman, N Begum, M G Ahmed, M
A Islam, O.I.Jordar. (2003).Clonal propagation of Averrhoa carambola
Linn. Through nodal culture of mature tree. Journal of Biological
Sciences,3(12): 1153-1157.
98. Mandar Medhi. (2014). Eco-friendly synthesis of Silver Nanoparticles
Using Fruit extract of Averrhoa carambola. International Journal of
Innovative Science, Engineering & Technology,1(4):479-482.
99. Md. Al Nayem Chowdhury, M. Ashrafuzzaman, Md. Hazrat Ali, Lutfun
Nahar Liza, Kazi Mohammad Ali Zinnah. (2013) Antimicrobial
Activity of Some Medicinal Plants against Multi Drug Resistant
Human Pathogens. Advances in Bioscience and
Bioengineering,1(1):1-24.
100. Joysree Das , Zulon Datta, Ayan Saha, Suza Mohammad Nur, Prosenjit
Barua, Md. Mominur Rahman, Kazi Ashfak Ahmed Chowdhury,
Mohammad Mostofa Chowdhury, Rabiul Hossain Chowdhury, Adnan
Mannan (2013). A comprehensive study on antioxidant, antibacterial,
cytotoxic and phytochemical properties of averrhoa carambola.
International. Journal of Bioassays, 02(05): 803-807.
236
236
101. C.K. Ngan, A.M. Khairatul and S. Mohammad Shahid. (2012)
Determination of proposed maximum residue limit of cypermethrin in
starfruit (Averrhoa carambola) Journal of Tropical Agriculture and Food
Science. 40(1): 99– 106.
102. Avinash G. Patil, Darshana A. Patil, Abhishek J. Sharma and Naresh
Chandra. (2011), Comparative in Vitro Antioxidant Activity and HPTLC
Fingerprint of Averrhoabilmbi Linn. andAverrhoacarambola Linn. Fruit
Extracts. Asian Journal of Experimental Science, 25(1): 93-102.
103. Chien-Liang Chen, Kang-Ju Chou, Jyh-Seng Wang, Jeng-Hsien Yeh,
Hua-Chang Fang, and Hsiao-Min Chung. (2002) Neurotoxic Effects Of
Carambola In Rats: The Role Of Oxalate. Journal of Formosa Medical
Association, 101:337–341.
104. S.B Badgujar and M.B Patil. (2008) Ethnomedicines for jaundice used in
tribal areas of Nrth Maharashtra. Natural Products radiance, 7(1):79-81.
105. Shejuty Shahreen, Joyanta Banik, Abdul Hafiz, Shahnaz Rahman,
Anahita Tanzia Zaman, Md. Abu Shoyeb, Majeedul H. Chowdhury,
Mohammed Rahmatullah. (2012) Antihyperglycemic Activities Of Leaves
Of Three Edible Fruit Plants (Averrhoa Carambola, Ficus Hispida And
Syzygium Samarangense) Of Bangladesh. African Journal of Traditional
Complementary and Alternative Medicine,9(2):287-291.
106. Sumitra Chanda, Dilip Bhayani and Dishant Desai (2013) polyphenols
and flavonoids of twelve indian medicinal plants. The Bioscan 8(2): 595-
601.
107. B Jyothi, S. Mohana lakshmi, K. Anitha. (2013) Evaluation of
hepatoprotective effect of Averrhoa carambola L. leaves on anti-
tubercular drugs induced hepato- toxicity. International Journal of
Pharmaceutical Research and Development, 5(3):302-309.
237
237
108. Nguyen Phuoc Minh. (2014) Utilization of ripen star fruit for vinegar
ferment- ation. International Journal of Multidisciplinary Research and
Development; 1(4): 82-93.
109. Jyoti Bala Chauhan, Wethroe Kapfo , Gulnaz AR. (2015) In vitro
comparative study of Bilimbi and Star fruit extracts for Anthelmintic
activity. Discovery Biotechnology, 6(15): 5-8
110. Sreeja Nair, Jacob George, Sajeev Kumar, and Noble Gracious (2014)
Acute Oxalate Nephropathy following Ingestion of Averrhoa bilimbi Juice.
Case Reports in Nephrology Volume 2014, Article ID 240936, 5 pages.
111. Aklima, J., Mojumder, S. and Sikdar, D. (2014) Total phenolic content,
reducing power, antioxidative and anti-amylase activities of five
Bangladeshi fruits. International Food Research Journal, 21(1): 119-124.
112. M. C. Z Hassan , N. A. B. Ramli (2014). Production of acetic acid from
bilimbi (averrhoa bilimbi) using culture medium. 2 nd International
Congress on Food Technology; November 05-07, Turkey Association of
Food Technology & Ankara University, Turkey P.207.
113. Kitti Bodhipadmaa, Sompoch Noichindaa , Noppavan Chanunpanichb ,
Pornporm Thongmeethipa , Pussadee Chalermwanitkula , David W.M.
Leungc. (2011) Differential response of callus initiation and growth of
aromatic chilli and bilimbi to two different electrospun nanofibre mats,
ScienceAsia 37 : 303–307.
114. Marsudin Silalahi, S. Sinaga and P.T. Sihombing. (2012) Effect of Wuluh
star fruit juice (Averrhoa bilimbi) on fat digestibility, protein efficiency ratio
and rate of feed in pig’s digest system Proceedings of International
Conference on Livestock Production and Veterinary Technology
2012:199-203.
238
238
115. Gunawan, Arlene Cordero and Anamy Paano1,(2013) Structure
Elucidation Of Two New Phytol Derivatives, A New Phenolic Compound
And Other Metabolites Of Averrhoa Bilimbi. Proceedings of the Research
Congress 2013 De La Salle University Manila March 7-9. FNH-I-008.
116. Nurul Najidah Mohamed , Lai Sin Yuan , Lee Siew Ling , Ho Chin Siong ,
Sheela Chandren , Hadi Nur.(2014) Preparation of Hierarchical Porous
Carbon Derived from Averrhoa Bilimbi and Its Diffusion Properties. Jurnal
Teknologi (Sciences & Engineering) 69(5):61–64.
117. Bhaurav. T. Dangat, Anuja .A. Shinde, Dipali N. Jagtap, Varsharani R.
Desai, Prachi B. Shinde, and Rajaram. V. Gurav. (2014) Mineral Analysis
of Averrhoa bilimbi L. – a potential fruit. Asian Journal of Pharmaceutical
and Clinical Research,7(3):150-151.
118. Precious Love A. Agena, Coren Jane P. Albay, Celestine L. Apusen,
Mary Rose M. Arago, Janina Camille E. Catapang & Rheinmark Lloyd S.
Siapco. (2012) Topical administration of Averrhoa bilimbi Linn. Leaves
crude extract prevents UVB-induced oxidative damage in albino mice.
The seventh Volume, 6:29-41.
119. Thamizh Selvam N., Santhi P. S., Sanjayakumar Y. R., Venugopalan T.
N., Vasanthakumar K. G. and Swamy G. K. (2015) Hepatoprotective
activity of Averrhoa bilimbi fruit in acetaminophen induced hepatotoxicity
in wistar albino rats. Journal of Chemical and Pharmaceutical
Research,7(1):535-540.
120. Cut Fauziah , Sri Fitriyani, Viona Diansari (2012). Colour Change of
Enamel after Application of Averrhoa bilimbi. Journal of Dentistry
Indonesia,19(3) 53- 56.
239
239
121. Manish Gunjan, Liswaria Karna, Kosheelah Dayalan ,Puvaneswaran
Sasigaran (2012) A Review and Search of Phytomedicine Used by
Traditional People of Malaysia (Ipoh, Perak). International Journal Of
Phytothearpy Research, 2(3):26- 41.
122. Aprilita Rinayanti, Hikmah , Rasi Bangun and Sri Teguh Rahayu. (2013)
Effect Of Ethanol Extract Starfruit leaves (Averrhoa bilimbi L.) in inhibit
renal calcium stone formation in in rat. International Journal of Pharmacy
Teaching & Practices 4(2):546
123. Rassami. W and Soonwera M,(2013) invitro pedicullisidal activity of
herbal shampoo base on Thai local plants against head louse (Pediculus
humanus capitus de Geer). Parasitology Research, 112(4):1411-1416.
124. S. L. Soumya & Bindu R. Nair (2013) Floral morphological features and
variability in two species of Averrhoa L. (Oxalidaceae). The International
Journal of Plant Reproductive Biology 5(2):200-209.
125. K. Girija and L Lakshmanan (2011)Anti- hyperlipidemic activity of
methanolic extracts of three plants of Amaranthus in Triton WR 1339
induced hyperlipidemic rats. Asian Pacific Journal of Tropical
Biomedicine 2011:S62- S65.
126. Varsha Dhulasavant, Shubhangi Shinde, Mangesh Pawar, N.S. Naikwade
(2010) Antihyperlipidemic Activity of Cinnamomum tamala Nees. on High
Cholesterol Diet Induced Hyperlipidemia. International Journal of
PharmTech Research2(4):2517-2521.
127. Ahmad Movahedian,I Behzad Zolfaghari,II S.Ebrahim Sajjadi, II Reza
MoknatjouI (2010) Antihyperlipidemic effect of Peucedanum
pastinacifolium extract in streptozotocin induced diabetic rats.
Clinics,65(6):629-633.
240
240
128. Anonymous (2001). The Ayurvedic Pharmacopoeia of India. Vol.1.
Part.1. Page. 56-57.
129. Anonymous (1996). The Indian Pharmacopoeia. Vol.2. Page. A-53, A-70.
130. Madhu. C. Diwakar (2002) Plant Drug evaluation. Page. 57.
131. Anonymous (2002) Quality control methods of Medicinal Plant Materials.
WHO. Page.46.
132. J.B. Harbone (1984) Phytochemical Methods, A Guide to Modern
Tedhnique of Plant Analysis. Page. 4-8.
133. Handa SS, Khanuja SPS, Longo G, Rakesh DD. (2008) Extraction
Technologies for Medicinal and Aromatic Plants. International centre for
science and high technology, Trieste, Page. 21-25.
134. Kokate.C.K, (1994) Practical pharmacognosy,7th edition ; Vallabh
Prakashan; Page. 112.
135. Roopashree TS, Dang R, Rani SRH, Narendra C. (2008) Antibacterial
activity of anti-psoriatic herbs: Cassia tora, Momordica charantia and
Calendula officinalis. International Journal of Applied Research in Natural
Products, 1(3): 20-28.
136. Obasi NL, Egbuonu ACC, Ukoha PO, Ejikeme PM. (2010) Comparative
phytochemical and antimicrobial 25. screening of some solvent extracts of
Samanea saman pods. African journal of pure and applied chemistry,
4(9): 206- 212.
137. Audu SA, Mohammed I, Kaita HA. (2007) Phytochemical screening of the
leaves of Lophira lanceolata (Ochanaceae). Life Science Journal, 4(4):
75-79.
241
241
138. P.D.Sethi (1996) High Performance Thin Layer Chromatography 2nd
edition. Page.3-26.
139. Merlin NJ, Parthasarathy V, Manavalan R, Kumaravel S, (2009)Chemical
Investigation of Aerial Parts of Gmelina asiatica Linn by GC-MS.
Pharmacognosy Research. 1(3): 152- 156.
140. S. Gopala Krishnan, E Vadivel. (2011) GC-MS Analysis of some bio
active constituents of Mussaeanda frontosa Linn. International Journal of
Pharma and biosciences,2(1):313-320.
141. Raymond G. Reid, Satyajit Srkar. (2012) Isolation of Natural products by
Low Pressure, Column Chromatography: Natural Products isolation,
Springer Protocol. Page 155-187.
142. Richard J P Cannel. (1998). Natural Products isolation. Hermane Press,
New Jersy. Page. 111-112.
143. Robert M Silverstein, Francis X Webster. (2011) Spectrometric
idendification of Organic compounds, 6thedition, Wiley India.Page2-249.
144. Kemp W, (1991) Organic Spectroscopy. MacMillan Press Ltd,
London.Page 1- 416.
145. Sethi PD.(2008) Quantitative analysis of drugs in pharmaceutical
formulations. CBS Publishers, Delhi. Page. 1-643.
146. Avanappa Srrinivasa Rao, Namburi Baghya Lakshmi. (2014)
Pharmacological Screening methods and toxicology. Pharma med Press
Hyderabad. Page. 277- 279.
147. Asare GA, Addo P, Bugyei K, Gyan B, Adjei S, Otu-Nyarko LS, Wiredu
EK, Nyarko A. (2011) Acute toxicity studies of aqueous leaf extract of
Phyllanthus niruri; Interdisciplinary Toxicology. 4(4):206-210.
242
242
148. Harsh Mohan. (2010) Text Book of Pathology, sixth edition, Jaypee
brothers medical publishers. Page. 393-395.
149. Vogel H G and Vogel W H. (1997) Drug Discovery and Evaluation
Pharmacological assays, Springer Verlag, Berlin, Page.598.
150. Miller G J and Miller N E. (1975) Plasma- HDL Concentration and
development of Ischaemic Heart Disease. Lancet. 1:16-19.
151. Gotto AM Jr, LaRosa JC, Hunninghake D. (1990) The cholesterol facts. A
summary of the evidence relating dietary facts, serum cholesterol and
coronary heart disease, Circulation .81:1721-1733.
152. Buchwald H, Varco RL, Matts JP. (1990) Effect of partial ileal bypass on
mortality and morbidity from coronary heart disease in patients with
hypercholesterolemia report of the program on the Surgical Control of
Hyperlipidaemias. New England. Journal of Medicine. 323: 946-55.
153. Hossam M.M. Arafa. (2005) Curcumin attenuates dietinduced
hypercholesterem-ia in rats. Medical Science Monitoring.11(7): 228-234.
154. Jain G.C, S. Jhalani, S. Agarwal and K. Jain. (2007) Hypolipidemic and A
ntiatherosclerotic Effect of Leptadenia pyrotechnica Extract in Cholesterol
Fed Rabbits Asian Journal of Experimental. Science. 21(1) 115-122.
155. Metwally, M.A.A ,A.M. El-Gellal and S.M. El Sawaisi. (2009) Effects of
Silymarin on Lipid Metabolism in Rats. World Applied Sciences Journal 6
(12): 1634-1637.
156. Dubey Sonal and Pande V.V. (2008) Antihyperlipidemic activity of
Sphaeranthus indicus on Atherogenic diet induced hyperlipidemia in rats,
International journal of green pharmacy. 2(8):208.
243
243
157. Oliver Bever B.(1986) Oral hypoglycemic action of medicinal plants in
tropical West Africa. Cambridge University Press, London. Page 245-267.
158. Rai MK. (1995)A review on some antidiabetic plants of India. Ancient
Science of Life, 14, Page. 42-54.
159. Sarti C, Gallagher J. (2006) The metabolic syndrome: prevalence, CHD
risk, and treatment. Journal of Diabetes Complications, 20: 121-132.
160. Scheen, JA. (1990) Drug treatment of non-insulin dependent diabetes
mellitus in the 1990s. Achievement and future development drugs, 54:
355-368.
161. Shukla R, Sharma SB, Puri D, Pabhu KM, Murthy PS. (2006) Medicinal
plants for treatment of diabetes mellitus. Indian Journal of. Clinical.
Biochemistry. 156: 169-177.